FLT4 anticorps (C-Term)
Aperçu rapide pour FLT4 anticorps (C-Term) (ABIN1839820)
Antigène
Voir toutes FLT4 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Purification
- Immunoaffinity purified
-
Immunogène
-
A synthetic peptide derived from C-terminus of human Flt-4.
Type of Immunogen: Synthetic peptide
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 10 mM PBS, pH 7.4, BSA, sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Do not freeze.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 2-8°C. Do not freeze.
-
-
- FLT4 (Fms-Related Tyrosine Kinase 4 (FLT4))
-
Autre désignation
- FLT4 / VEGFR3
-
Sujet
-
Name/Gene ID: FLT4
Subfamily: VEGF Receptor
Family: Protein Kinase
Synonyms: FLT4, FLT41, Fms-related tyrosine kinase 4, Fms-like tyrosine kinase 4, LMPH1A, PCL, Soluble VEGFR3 variant 1, Vegf-r3, VEGFR3, Soluble VEGFR3 variant 2, Soluble VEGFR3 variant 3, FLT-4, Quek2, VEGF Receptor 3, VEGFR-3 -
ID gène
- 2324
-
Pathways
- Signalisation RTK, Signaling Events mediated by VEGFR1 and VEGFR2, VEGF Signaling
Antigène
-